Bosschaerts et al., 2011 - Google Patents

IL‐10 limits production of pathogenic TNF by M1 myeloid cells through induction of nuclear NF‐κB p50 member in Trypanosoma congolense infection‐resistant …

Bosschaerts et al., 2011

View PDF @Full View
Document ID
12967981328361817136
Author
Bosschaerts T
Morias Y
Stijlemans B
Hérin M
Porta C
Sica A
Mantovani A
De Baetselier P
Beschin A
Publication year
Publication venue
European journal of immunology

External Links

Snippet

A balance between parasite elimination and control of infection‐associated pathogenicity is crucial for resistance to African trypanosomiasis. By producing TNF and NO, CD11b+ myeloid cells with a classical activation status (M1) contribute to parasitemia control in …
Continue reading at onlinelibrary.wiley.com (PDF) (other versions)

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
    • A61K47/48—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells

Similar Documents

Publication Publication Date Title
Bosschaerts et al. IL‐10 limits production of pathogenic TNF by M1 myeloid cells through induction of nuclear NF‐κB p50 member in Trypanosoma congolense infection‐resistant C57BL/6 mice
Hinks et al. MAIT cell activation and functions
Carestia et al. Platelets promote macrophage polarization toward pro-inflammatory phenotype and increase survival of septic mice
Rothlin et al. Lifting the innate immune barriers to antitumor immunity
Eyles et al. A key role for G-CSF–induced neutrophil production and trafficking during inflammatory arthritis
Stoecklein et al. Trauma equals danger—damage control by the immune system
Villegas-Mendez et al. IFN-γ–producing CD4+ T cells promote experimental cerebral malaria by modulating CD8+ T cell accumulation within the brain
Bischoff et al. Mast cells are an important cellular source of tumour necrosis factor α in human intestinal tissue
Ohradanova-Repic et al. Extracellular purine metabolism is the switchboard of immunosuppressive macrophages and a novel target to treat diseases with macrophage imbalances
Okeke et al. CD4+ CD25+ regulatory T cells attenuate lipopolysaccharide-induced systemic inflammatory responses and promotes survival in murine Escherichia coli infection
Chandawarkar et al. Immune modulation with high‐dose heat‐shock protein gp96: therapy of murine autoimmune diabetes and encephalomyelitis
Guilliams et al. African trypanosomiasis: naturally occurring regulatory T cells favor trypanotolerance by limiting pathology associated with sustained type 1 inflammation
Varma et al. Cellular mechanisms that cause suppressed gamma interferon secretion in endotoxin-tolerant mice
McKay et al. Kidney transplantation and the ageing immune system
Canetti et al. Tumour necrosis factor‐alpha and leukotriene B4 mediate the neutrophil migration in immune inflammation
Mohr et al. Sepsis leads to a reduced antigen‐specific primary antibody response
Tierney et al. Type II‐activated macrophages suppress the development of experimental autoimmune encephalomyelitis
Zhao et al. Growth Arrest‐Specific 6 Enhances the Suppressive Function of CD4+ CD25+ Regulatory T Cells Mainly through Axl Receptor
Roux et al. Neonatal lung immune responses show a shift of cytokines and transcription factors toward Th2 and a deficit in conventional and plasmacytoid dendritic cells
Salei et al. Enhanced survival of Leishmania major in neutrophil granulocytes in the presence of apoptotic cells
Ngoi et al. Presensitizing with a Toll-like receptor 3 ligand impairs CD8 T-cell effector differentiation and IL-33 responsiveness
Toribio-Fernández et al. Lamin A/C augments Th1 differentiation and response against vaccinia virus and Leishmania major
Poncini et al. Dual role of monocyte‐derived dendritic cells in Trypanosoma cruzi infection
Monari et al. Modulation of C5aR expression on human neutrophils by encapsulated and acapsular Cryptococcus neoformans
Flores-García et al. CD4+ CD25+ FOXP3+ Treg cells induced by rSSP4 derived from T. cruzi amastigotes increase parasitemia in an experimental Chagas disease model